More interestingly, we found that high expression of CCND1 may lead to resistance to multiple anti-colon cancer drugs based on the GSCALite database (Additional file 7: Fig. S1), which contains 5-fluorouracil, methotrexate, cetuximab and so on. This evidence concerns the gene CCND1 and malignant colon neoplasm.